merged_eu-covid-vaccines.txt
<question_number>1</question_number>
<answer>The court ruling could weaken von der Leyen's chances by bolstering criticism from those who are already skeptical of her leadership, potentially costing her votes.</answer>
<question_number>2</question_number>
<answer>The article implies that concerns about a lack of transparency and potential misuse of taxpayer money in the EU's vaccine procurement, overseen by von der Leyen, have fueled distrust among voters, potentially contributing to the rise of far-right parties.</answer>
<question_number>3</question_number>
<answer>The article suggests that von der Leyen's handling of the vaccine contracts has strained her relationship with the Greens in the European Parliament, whose support she needs for re-election.</answer>
<question_number>4</question_number>
<answer>The article implies that the lack of transparency surrounding the EU's vaccine procurement strategy, a key part of von der Leyen's pandemic response, has contributed to a climate of distrust that has benefited far-right politicians.</answer>
<question_number>5</question_number>
<answer>The court's ruling fuels existing concerns about transparency and accountability in the EU, potentially further eroding public trust and benefiting far-right parties who capitalize on such sentiments.</answer>
<question_number>6</question_number>
<answer>The timing of the court's ruling, just before the vote on von der Leyen's future, could negatively impact her chances by bringing the issue of vaccine contract transparency to the forefront of the debate.</answer>
<question_number>7</question_number>
<answer>The EU's vaccine procurement strategy under von der Leyen shifted from an initially cautious and budget-conscious approach to a more aggressive strategy that resulted in a surplus of vaccines.</answer>
<question_number>8</question_number>
<answer>The European Commission's statement emphasizes the need to balance transparency with protecting business interests, yet the court ruled that they did not adequately demonstrate this balance in their handling of the vaccine contracts.</answer>
<question_number>9</question_number>
<answer>Both the court's ruling and The New York Times' pending legal case center on the issue of transparency and access to information regarding the EU's vaccine contracts.</answer>
<question_number>10</question_number>
<answer>The court's ruling could further erode public trust in the EU's pandemic response, particularly among those already inclined towards far-right narratives that criticize the EU's handling of the crisis.</answer>